Scholarlink

<p>Despite advances in percutaneous coronary intervention (PCI) and contemporary secondary prevention, recurrent cardiovascular events remain a major clinical challenge. Increasing evidence suggests that persistent vascular inflammation contributes to residual cardiovascular risk after PCI, even in patients receiving optimal lipid-lowering therapy. Recent studies have highlighted the clinical relevance of inflammatory biomarkers, plaque vulnerability, and intracoronary imaging findings in predicting adverse cardiovascular outcomes. In addition, anti-inflammatory therapeutic strategies have emerged as promising approaches for residual risk reduction. This review summarizes current insights into the mechanisms, assessment, and potential therapeutic implications of residual inflammatory risk after PCI.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Residual inflammatory risk after percutaneous coronary intervention: current insights and future perspectives

  • 期刊论文

  • 发表日期：

    2026年6月23日

查看全文
  • Tomoya Hara,
  • Masataka Sata

摘要

Despite advances in percutaneous coronary intervention (PCI) and contemporary secondary prevention, recurrent cardiovascular events remain a major clinical challenge. Increasing evidence suggests that persistent vascular inflammation contributes to residual cardiovascular risk after PCI, even in patients receiving optimal lipid-lowering therapy. Recent studies have highlighted the clinical relevance of inflammatory biomarkers, plaque vulnerability, and intracoronary imaging findings in predicting adverse cardiovascular outcomes. In addition, anti-inflammatory therapeutic strategies have emerged as promising approaches for residual risk reduction. This review summarizes current insights into the mechanisms, assessment, and potential therapeutic implications of residual inflammatory risk after PCI.